Log In
Print
BCIQ
Print
Print this Print this
 

AMG 876

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionFusion protein
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today